Document is current

Article History

Received: 20 September 2024

Accepted: 7 March 2025

First Online: 7 April 2025

Declarations

:

: This public opinion research was conducted in accordance with applicable national guidelines, and therefore, formal ethical approval was not required, as the participants were non-identified and the information collected did not allow for individual identification. All participants were informed about the purpose of the study and consented to participate voluntarily.

: Informed consent was obtained.

: LFV reports payment or honoraria from Novo Nordisk and AstraZeneca; travel/meeting support from Novo Nordisk and Eli Lilly and Company. FM reports have been employed by Merck KGaA. CMV reports payment or honoraria from Eli Lilly and Company, Novo Nordisk, Merck S.A., PTC, Chiesi and Boehringer-Ingelheim; travel/meeting support from Novo Nordisk, Eli Lilly and Boheringer-Ingelheim; participation on Advisory Board for Eli Lilly, Novo Nordisk and Chiesi; receipt of equipment, materials, drugs, medical writing, gifts or other services from Chiesi-Amryt; and is a Member of the Board of Directors of the Brazilian Association of Obesity. MAB reports being employed by Merck KGaA. BH reports payment or honoraria from Eli Lilly and Company, Novo Nordisk, Merck S.A., AstraZeneca and Abbott Nutrition; travel/meeting support from Novo Nordisk; participation on a Data Safety Monitoring Board or Advisory Board for Eli Lilly, Novo Nordisk and Merck S.A; receipt of equipment, materials, drugs, medical writing, gifts or other services from Eli Lilly and Company and Novo Nordisk; and is President of the Brazilian Association of Obesity and a Member of Board of Trustees of World Obesity Federation representing Latin America.